Clinical Trial Update: A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rotigotine transdermal patch for early morning motor impairment and sleep disorders in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine transdermal patch (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: IDIOPATHIC PARKINSON'S DISEASE | Phase 3 | Status: COMPLETED